Article

Priority age targets for COVID-19 vaccination in Ethiopia under limited vaccine supply

2022-07-31

Abstract excerpt

<h4>Background</h4> The worldwide inequitable access to vaccination claims for a re-assessment of policies that could minimize the COVID-19 burden in low-income countries. An illustrative example is what occurred in Ethiopia, where nine months after the launch of the national vaccination program in March 2021, only 3% of the population received two doses of COVID-19 vaccine. In the meantime, a new wave of cases ca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e8dfe034-f643-536f-8057-3944fdf4bf43
DOI: 10.1101/2022.07.28.22278142

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Priority age targets for COVID-19 vaccination in Ethiopia under limited vaccine supplyDOI 10.1101/2022.07.28.22278142Read

Projecting the transition of COVID-19 burden towards the young population while vaccines are rolled out: a modelling studySemantic proximity Read

Projecting the Transition of COVID-19 Burden Towards the Young Population While Vaccines are Rolled Out: A Modelling StudySemantic proximity Read

Global, regional, and national estimates of target population sizes for COVID-19 vaccinationSemantic proximity Read

Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European RegionSemantic proximity Read

Impact of age-structure and vaccine prioritization on COVID-19 in West AfricaSemantic proximity Read

Long term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: a modelling studySemantic proximity Read

Cost-effectiveness of routine COVID-19 adult vaccination programmes in EnglandSemantic proximity Read

COVID-19 vaccine coverage targets to inform reopening plans in a low incidence settingSemantic proximity Read

Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: a multi-model studySemantic proximity Read

Long Term Vaccination Strategies to Mitigate the Global Impact of SARS-CoV-2 Transmission: A Modelling StudySemantic proximity Read

Critical assessment of the impact of vaccines and waning/boosting of immunity on the burden of COVID-19 in the U.SSemantic proximity Read

Herd immunity induced by COVID-19 vaccination programs and suppression of epidemics caused by the SARS-CoV-2 Delta variant in ChinaSemantic proximity Read